ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 20 filers reported holding ALPINE IMMUNE SCIENCES INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,501 | -84.7% | 17,511 | -86.2% | 0.00% | -100.0% |
| Q2 2023 | $1,308,901 | +1049.4% | 127,325 | +763.2% | 0.00% | – |
| Q1 2023 | $113,877 | +90.0% | 14,751 | +80.9% | 0.00% | – |
| Q4 2022 | $59,939 | +3.3% | 8,155 | +1.3% | 0.00% | – |
| Q3 2022 | $58,000 | -24.7% | 8,049 | -11.4% | 0.00% | – |
| Q2 2022 | $77,000 | +35.1% | 9,089 | +44.3% | 0.00% | – |
| Q1 2022 | $57,000 | -41.8% | 6,300 | -10.5% | 0.00% | – |
| Q4 2021 | $98,000 | +38.0% | 7,042 | +5.4% | 0.00% | – |
| Q3 2021 | $71,000 | -94.1% | 6,680 | -95.0% | 0.00% | -100.0% |
| Q2 2021 | $1,207,000 | -53.4% | 134,057 | -45.1% | 0.00% | 0.0% |
| Q1 2021 | $2,590,000 | +64650.0% | 244,332 | +22842.0% | 0.00% | – |
| Q4 2019 | $4,000 | +300.0% | 1,065 | +163.0% | 0.00% | – |
| Q4 2018 | $1,000 | -99.8% | 405 | -99.4% | 0.00% | – |
| Q3 2018 | $433,000 | -29.6% | 68,528 | -15.7% | 0.00% | – |
| Q2 2018 | $615,000 | +104.3% | 81,338 | +115.9% | 0.00% | – |
| Q1 2018 | $301,000 | +56.0% | 37,680 | +117.9% | 0.00% | – |
| Q4 2017 | $193,000 | -24.9% | 17,292 | -22.2% | 0.00% | – |
| Q3 2017 | $257,000 | – | 22,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 4,708,288 | $42,233,000 | 12.94% |
| Lynx1 Capital Management LP | 1,484,693 | $13,318,000 | 12.36% |
| Omega Fund Management, LLC | 2,029,580 | $18,205,000 | 3.73% |
| TCG Crossover Management, LLC | 1,034,222 | $9,277,000 | 3.72% |
| Frazier Life Sciences Management, L.P. | 4,185,757 | $37,546,000 | 3.20% |
| Paradigm Biocapital Advisors LP | 336,229 | $3,016,000 | 0.80% |
| Orbimed Advisors | 4,081,592 | $36,612,000 | 0.59% |
| BVF INC/IL | 1,589,495 | $14,258,000 | 0.57% |
| Kingsbury Capital Investment Advisors LLC | 29,153 | $262,000 | 0.29% |
| Avidity Partners Management LP | 1,207,000 | $10,827,000 | 0.22% |